Journal for ImmunoTherapy of Cancer Q1 Unclaimed
Journal for ImmunoTherapy of Cancer is a journal indexed in SJR in Pharmacology and Molecular Medicine with an H index of 100. It is an CC BY Journal with a Single blind Peer Review review system, and It has a price of 1694 €. The scope of the journal is focused on tumour immunology, cancer immunotherapy, immunotherapy biomarkers. It has an SJR impact factor of 3,403 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 3,403.
Journal for ImmunoTherapy of Cancer focuses its scope in these topics and keywords: immunotherapy, response, cancer, cell, tumor, carcinoma, annual, society, therapy, patient, ...
Type: Journal
Type of Copyright: CC BY
Languages: English
Open Access Policy: Open Access
Type of publications:
Publication frecuency: -
1694 €
Inmediate OANPD
Embargoed OA- €
Non OAMetrics
3,403
SJR Impact factor100
H Index537
Total Docs (Last Year)1397
Total Docs (3 years)20980
Total Refs14294
Total Cites (3 years)1385
Citable Docs (3 years)8.88
Cites/Doc (2 years)39.07
Ref/DocOther journals with similar parameters
Pharmacological Reviews Q1
Drug Resistance Updates Q1
Annual Review of Pharmacology and Toxicology Q1
Molecular Therapy Q1
Pharmacology and Therapeutics Q1
Compare this journals
Comments